Srinivasan T, Mallik N, Sachdeva MUS, Bose P, et al. CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T-Cell Acute Lymphoblastic Leukemia. Eur J Haematol 2025 Sep 13. doi: 10.1111/ejh.70035.
PMID: 40944441